The Peter Attia Drive · Podcast summary
#406 ‒ Migraine, cluster headache, and tension headache: symptoms, causes, prevention, and treatment | Brian Grosberg, M.D.
Dr. Brian Grosberg, a leading headache specialist, discusses the nuances of migraine, cluster headaches, and tension headaches, covering symptoms, causes, prevention, and the latest treatment strategies.
Listen on the show ↗Key takeaways
- 🧠Dr. Grosberg highlights the significant gap in medical education regarding headaches, with medical students and residents receiving only a few hours of specialized training despite headaches being one of the most common neurological symptoms.3:11
- 📝A detailed headache diary is a critical tool for both patients and clinicians, empowering patients to understand their patterns and providing invaluable information for accurate diagnosis and personalized treatment plans.4:12
- 🔍Unlike many medical conditions, primary headaches lack objective biomarkers or imaging findings (like a CT or MRI scan), making a detailed patient history the most crucial tool for diagnosis.7:51
- 💸The economic impact of migraine, particularly due to presenteeism (people showing up to work but not operating at full capacity), is estimated to be in the billions of dollars annually.20:58
- 🚶♀️Migraine is not just a headache but a neurological disease with distinct phases: prodrome, aura, headache, and postdrome. Many sufferers are significantly impacted but continue daily activities, making it an "invisible disease."22:11
- ♀️Migraine disproportionately affects women, with 18% of women experiencing it compared to 6% of men, meaning almost one in five women suffer from migraine.22:43
Chapters
- 0:11Introduction to Headaches and the Drive Podcast
- 1:44Dr. Brian Grosberg's Background and Journey into Headache Medicine
- 8:31The Challenge of Diagnosing Headaches Without Biomarkers
- 14:04Primary vs. Secondary Headaches: Classification and Causes
- 16:47Neuromodulation Devices for Headache Prevention and Treatment
- 18:41Tension-Type Headaches: Symptoms and Characteristics
- 20:22Migraine: Symptoms, Phases (Prodrome, Aura, Headache, Postdrome), and Diagnosis
- 33:45The Societal and Economic Burden of Migraine
- 37:23Migraine Prevalence, Gender Disparity, and the Shortage of Specialists
- 39:58Episodic vs. Chronic Migraine
- 42:08Genetics, Hormones, and Environmental Factors in Migraine
- 1:08:45The Importance of a Headache Diary
- 1:25:30Lifestyle Modifications for Headache Management
- 1:45:38CSF Leaks and Other Secondary Headache Causes
- 1:48:53Goals of Preventive Therapy for Headaches
- 1:55:23Preventive Medications: Beta-Blockers, Antidepressants, Anti-Epileptics
- 2:05:13CGRP Antagonists: A Game-Changer in Migraine Treatment
- 2:34:09Acute Treatment Strategies for Headaches: Triptans, Gepants, and Others
The digest
Dr. Brian Grosberg, an internationally recognized headache specialist and director of the Hartford HealthCare Headache Program, joins Peter Attia to demystify the complex world of headaches. This episode delves into the classification, causes, and cutting-edge treatments for migraine, cluster headaches, and tension headaches, offering invaluable insights for both patients and clinicians.
The Under-Recognized Burden of Headaches
Headaches are one of the most common neurological symptoms, with nearly every person experiencing one at some point in their life. Despite this prevalence, Dr. Grosberg highlights a significant gap in medical education, noting that medical students and residents receive only a few hours of headache-specific training. This lack of specialized education contributes to the widespread misunderstanding and underdiagnosis of conditions like migraine, which affects tens of millions of people. The economic impact of headaches, particularly in terms of presenteeism (people showing up to work but not operating at full capacity), is estimated to be in the billions of dollars annually, underscoring the immense societal burden.
Keep reading in The Digest
The full 6-minute article, 10 more sections, and every new episode from The Peter Attia Drive and the creators you follow.
- Classifying Headaches: Primary vs. Secondary
- The Big Three: Tension, Migraine, and Cluster Headaches
- Tension-Type Headache
- Migraine
- Cluster Headache
- Genetic, Hormonal, and Environmental Factors
- Lifestyle Modifications and Pharmacological Treatments
- Game-Changing CGRP Antagonists and Neuromodulation
- Acute Treatments and the Importance of a Headache Diary
- Hope for Headache Sufferers
More from The Peter Attia Drive
#409 ‒ Inside modern drug development: the science, economics, and regulatory hurdles behind bringing new medicines to patients | Lloyd Klickstein, M.D., Ph.D.
Dr. Lloyd Klickstein, a physician-scientist and drug developer, unpacks the complex journey of discovering and developing new medicines, using the muscle-preserving drug bimagrumab as a case study to reveal the science, economics, and regulatory challenges behind modern drug development.
#407 ‒ Preventing cardiovascular and Alzheimer's disease: lowering LDL early, APOE4, and promising new therapies | Michael Davidson, M.D.
Dr. Michael Davidson, a cardiologist and lipidologist, discusses the critical role of early LDL lowering in preventing cardiovascular disease, the nuanced understanding of APOE4 in Alzheimer's, and the potential of emerging therapies like obicetrapib and clotho.
Blood pressure: how to measure, manage, and treat high blood pressure (AMA #48 rebroadcast)
In this AMA, Peter Attia and his co-host discuss everything you need to know about blood pressure, including how to measure it, the consequences of high blood pressure, and how to manage and treat it through lifestyle and medication.
#405 ‒ AMA #88: Metabolic liver health: how to assess risk, catch dysfunction early, and prevent or reverse liver disease
Dr. Peter Attia discusses metabolic liver health, including how to assess risk, catch dysfunction early, and prevent or reverse liver disease.
#404 ‒ Mental health beyond neurotransmitters: the role of hormones in psychiatry, why symptom reduction isn't enough, and the future of psychedelic therapies | Linus Abrams, M.D.
Dr. Linus Abrams, a psychiatrist with 35 years of clinical experience, discusses the limitations of traditional psychiatry, the crucial role of hormones in mental health, and the potential future of psychedelic therapies.
#403 ‒ Peptides: separating scientific promise from marketing hype
Peter Attia and Nick Stenson discuss the current landscape of peptides, separating scientific promise from marketing hype, and providing a framework for evaluating any peptide you might encounter.